High numbers of clonal CD19+ cells in the peripheral blood of a patient with multiple myeloma

This publication has 11 references indexed in Scilit:

• Identification and characterisation of malignant cells using PT-PCR on single flow-sorted cells
  Medical Oncology, 1998
• Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement
  Leukemia, 1997
• Circulating Blood B Cells in Multiple Myeloma: Analysis and Relationship to Circulating Clonal Cells and Clinical Parameters in a Cohort of Patients Entered on the Eastern Cooperative Oncology Group Phase III E9486 Clinical Trial
  Blood, 1997
• CD34+ Cells in the Blood of Patients With Multiple Myeloma Express CD19 and IgH mRNA and Have Patient-Specific IgH VDJ Gene Rearrangements
  Blood, 1997
• CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells
  British Journal of Haematology, 1996
• Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells [see comments]
  Blood, 1996
• In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain [published erratum appears in Blood 1995 Jun 1;85(11):3365]
  Blood, 1995
• Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell
  British Journal of Haematology, 1994
• Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas.
  The Journal of Experimental Medicine, 1993
• The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
  The Journal of Experimental Medicine, 1993